(New York City) A new test may reveal which patients will respond to treatment for graft versus host disease (GVHD), an often life-threatening complication of stem cell transplants (SCT) used to treat leukemia and other blood disorders, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the journal Lancet Haematology and in print in the January issue.
Patients with fatal blood cancers like leukemia often require allogenic stem cell SCT to survive. Donor stem cells are transplanted to a recipient, but not without the risk of developing GVHD, a life-threatening complication and major cause of death after SCT. The disease, which can be mild to severe, occurs when the transplanted donor cells (known as the graft) attack the patient (referred to as the host). Symptom severity, however, does not accurately define how patients will respond to treatment and patients are often treated alike with high-dose steroids. Although SCT cures cancer in 50 percent of the patients, 25 percent die from relapsed cancer and there remaining go into remission but later succumb to effects of GVHD.
"High dose steroids is the only proven treatment for GVHD," said James L. M. Ferrara, MD, DSc, Ward-Coleman Chair in Cancer Medicine Professor at the Icahn School of Medicine at Mount Sinai, Director of Hematologic Malignancies Translational Research Center at Tisch Cancer Institute at Mount Sinai. "Those with low-risk GVHD are often over-treated and face significant side-effects from treatment. Patients with high risk GVHD are undertreated and the GVHD progresses, often with fatal consequences. Our goal is to provide the right treatment for each patient. We hope to identify those patients at higher risk and design an aggressive intervention while tailoring a less-aggressive approach for those with low-risk."
Dr. Ferrara, along with a multi-center team of researchers, developed and tested this new scoring system using almost 500 patient blood samples with newly diagnosed GVHD in varying grades from two different centers. They used three validated biomarkers TNFR1, ST2 and Reg3 to create an algorithm that calculated the probability of non-relapse mortality (usually caused by GVHD) that provided three distinct risk scores to predict the patient's response to GVHD treatment.
The acid test was to evaluate the algorithm in a validation set of 300 additional patients from twenty different SCT centers throughout the US. The algorithm worked perfectly, and the cumulative incidence of non-relapse mortality significantly increased as the GVHD score increased, and so the response rate to primary GVHD treatment decreased.
"This new scoring system will help identify patient who may not respond to standard treatments, and may require an experimental and more aggressive approach," said Dr. Ferrara. "And it will also help guide treatment for patients with lower-risk GVHD who may be over-treated. This will allow us to personalize treatment at the onset of the disease. Future algorithms will prove increasingly useful to develop precision medicine for all SCT patients."
In order to capitalize on this discovery, Dr. Ferrara has created the Mount Sinai Acute GVHD International Consortium (MAGIC) which consists of a group of ten SCT centers in the US and Europe who will collaborate to use this new scoring system to test new treatments for acute GVHD. Dr. Ferrara and colleagues have also written a protocol to treat high-risk GVHD that has been approved by the FDA.
###
Co-collaborators included University of Michigan, University of Regensburg, and the Blood and Marrow Clinical Trials Network.
The study was supported by grants from the National Cancer Institute; the National Heart, Lung, and Blood Institute, the National Institute of Allergy and Infectious Diseases, the Doris Duke Charitable Fund, the American Cancer Society, and the Judith Devries Fund.
Read more here:
Test predicts response to treatment for complication of leukemia stem cell treatment
- Duke Stem Cell and Regenerative Medicine Program - August 4th, 2016
- 13th Stem Cell Research & Regenerative Medicine Overview - August 4th, 2016
- Reviews - Cell Therapy News - August 4th, 2016
- Treatment | Stemgenn - August 4th, 2016
- Cell therapy could slow decline in heart failure patients ... - August 4th, 2016
- Issues Archive - Cell Therapy News - August 4th, 2016
- Worlds leading Stem Cell Conference | Global Meetings ... - August 4th, 2016
- Eli and Edythe Broad Center of Regeneration Medicine and ... - October 28th, 2015
- CAR T-Cell Immunotherapy for ALL - National Cancer Institute - October 27th, 2015
- Gene Therapy and Cell Therapy Defined | ASGCT - American ... - October 27th, 2015
- Cell Therapy Ltd - October 25th, 2015
- Cell Therapy & Regenerative Medicine - University of Utah ... - October 23rd, 2015
- Mississippi Stem Cell Treatment Center - Ocean Springs, MS - October 4th, 2015
- Regenerative Medicine and Stem cell based Cell therapies ... - October 4th, 2015
- Research - Stem Cell Biology and Regenerative Medicine ... - September 25th, 2015
- Stem Cell Treatment May Help Ease Osteoarthritis Pain ... - September 16th, 2015
- Knoepfler Lab Stem Cell Blog | Building innovative ... - September 11th, 2015
- Cell culture - Wikipedia, the free encyclopedia - September 7th, 2015
- Induced pluripotent stem cell - Wikipedia, the free ... - August 22nd, 2015
- What are Stem Cells? Medical News Today - August 15th, 2015
- Stem cell controversy - Wikipedia, the free encyclopedia - July 22nd, 2015
- Global Stem Cells Group, Stem Cell Training and Anti-aging ... - June 9th, 2015
- Stem Cells Adult Stem Cells & Stem Cell Treatments ... - May 12th, 2015
- Arthritic knees; 7 months after stem cell therapy by Harry Adelson, N.D. - Video - April 26th, 2015
- Stem Cell Treatment for COPD | StemRx Bioscience Solutions - Video - April 24th, 2015
- One type of airway cell can regenerate another lung cell type - April 13th, 2015
- Limber Lungs: One Type of Airway Cell Can Regenerate Another Lung Cell Type - April 13th, 2015
- Dr. Owen Witte recognized with AACR G.H.A. Clowes Memorial Award - April 7th, 2015
- Regenestem Network Announces Plans to Attend the 23rd Annual World Congress on Anti-Aging Medicine May 7-9, 2015 - April 7th, 2015
- 'Open' stem cell chromosomes reveal new possibilities for diabetes - April 3rd, 2015
- Stem Cell Grants for Spina Bifida and Diabetic Wound Treatments - March 30th, 2015
- Stem cell firm Cellular Dynamics being acquired by Japanese company for $307 million - March 30th, 2015
- UCI team gets $5 million to create stem cell treatment for Huntington's disease - March 26th, 2015
- Celprogen Released Stem Cell Active Ingredients for the Cosmetic Industry Tested and Validated in Cosmetic Products ... - March 26th, 2015
- Cleveland Clinic Researchers First to Demonstrate Significant Blocking of Opioid Tolerance With Mesenchymal Stem Cell ... - March 24th, 2015
- Asymmetrex Opens Up 5th World Congress on Cell and Stem Cell Research in Chicago with a Focus on Its New Technologies ... - March 24th, 2015
- stem cell medicine Jakarta tangerang serpong bsd bintaro - Video - March 21st, 2015
- Global Stem Cells Group to Hold Practical Adipose-Derived Stem Cell Harvesting, Isolation and Re-integration Training ... - March 19th, 2015
- BrainStorm Cell Therapeutics to Present at 3rd Annual Regen Med Investor Day on March 25 in New York - March 19th, 2015
- Boston Stem Cell Biotech Start-up Asymmetrex Will Present Essential Technologies for Stem Cell Medical Engineering at ... - March 18th, 2015
- A Single-Cell Breakthrough - March 18th, 2015
- Global Stem Cells Group to Participate in the 25th Argentine Congress of Aesthetic Medicine in Buenos Aires April 9-10 ... - March 18th, 2015
- A Single-Cell Breakthrough: newly developed technology dissects properties of single stem cells - March 18th, 2015
- Stem cells lurking in tumors can resist treatment - March 12th, 2015
- Boosting A Natural Protection Against Alzheimer's Disease - March 12th, 2015
- Media portray unrealistic timelines for stem cell therapies - March 12th, 2015
- Achieving gender equality in science, engineering and medicine - March 9th, 2015
- Seven strategies to advance women in science - March 9th, 2015
- British biotech firm sets crowdfunding record with heart drug - March 9th, 2015
- Targazyme Inc. Receives Orphan Drug Designation to TZ101 for Use With Regulatory T Cells to Prevent & Reduce the ... - March 9th, 2015
- Activating genes on demand: Possible? - March 6th, 2015
- Translational Regenerative Medicine: Market Prospects 2015-2025 - February 28th, 2015
- The Irvine Stem Cell Treatment Center Announces Adult Stem Cell Public Seminars in Riverside, Ontario, and Brea ... - February 27th, 2015
- The Miami Stem Cell Treatment Center Announces Adult Stem Cell Public Seminars in The Villages, Florida - February 26th, 2015
- New study shows safer methods for stem cell culturing - February 25th, 2015
- New Commentary from Asymmetrex LLC Director Anticipates Forthcoming E-Book on Stem Cell Genetic Fidelity - February 25th, 2015
- Researchers Hone in on Stem Cell that Speeds Healing of Stubborn Diabetes Wounds - February 25th, 2015
- Stem cellrecruiting hydrogels based on self-assembling peptides for tissue regeneration - February 24th, 2015
- Global Stem Cells Group, Inc. Announces Launch of New Stem Cell Harvesting Products - February 24th, 2015
- Global Stem Cells Group Announces Alliance with Advancells - February 17th, 2015
- Global Stem Cells Group Announces Alliance with Regenerative Technology - February 11th, 2015
- Biotech firm Cell Therapy claims crowdfunding record with heart drug - February 10th, 2015
- Two UC San Diego Scientists Receive Stem Cell Technology Grants - February 2nd, 2015
- UCLA Researchers Receive Prestigious CIRM Tools and Technologies Award - February 2nd, 2015
- Regenestem Network and Gilberto Hernandez Falcon, M.D. Open Stem Cell Clinic in Yucatan - January 31st, 2015
- Gordie Howe's stem cell therapy raises concerns among medical experts - January 30th, 2015
- Gordie Howe's stem cell therapy raises concerns among experts - January 30th, 2015
- Global Stem Cells Group and Regenestem Network Announce Launch of New Stem Cell and Regenerative Medicine Clinic in ... - January 29th, 2015
- Asymmetrex Scheduled to Present Unique Perspectives in Stem Cell Biology and Recent Advances in Technologies for Adult ... - January 29th, 2015
- Keeping the Kraken asleep - January 27th, 2015
- BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell Technology, and Cancer ... - January 26th, 2015
- The Miami Stem Cell Treatment Center Announces the Opening of a New Office in The Villages - January 24th, 2015
- Regenestem Network, a division of Global Stem Cells Group, Announces Launch of New Stem Cells and Regenerative ... - January 23rd, 2015
- Scientists announce revolutionary culturing technique for liver and pancreas - January 23rd, 2015
- The Miami Stem Cell Treatment Center Announces Adult Stem Cell Public Seminars in Naples, Florida - January 23rd, 2015
- Stanford researchers isolate stem cell that gives rise to bones, cartilage in mice - January 16th, 2015
- Global Stem Cells Group to Move Headquarters to Larger Miami Lakes Office Complex - January 14th, 2015
- Peter S. Kim Named the Virginia and D.K. Ludwig Professor of Biochemistry at Stanford - January 14th, 2015
- Renowned professor's book addresses stem cell biology & regenerative medicine - January 12th, 2015
- Cord Blood Banking Leader, Cryo-Cell International, Continues to Support the Advancement of Regenerative Medicine - January 7th, 2015